This article reports progress in the field of endocrinopathies and foc
uses on the molecular aspects of these diseases. Implications for gene
tics and metabolic study are presented. Although limitations of earlie
r approaches are confirmed, progress is noted, particularly with regar
d to the contribution of octreotide scintigraphy, Integrated with the
evolving applications of molecular insights, significant clinical prog
ress has been recorded.